Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

25.59
-0.1132-0.44%
Post-market: 25.590.00000.00%16:10 EDT
Volume:1K
Turnover:29.50K
Market Cap:5.12M
PE:- -
High:25.59
Open:25.51
Low:25.51
Close:25.70
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:1.52
T/O Rate:0.58%
Dividend:0.41
Dividend Rate:1.62%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14

Reuters
·
Sep 04

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

TIPRANKS
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Aspen Sees Mounjaro Africa Sales Above $124 Million in 2027

Reuters
·
Sep 03

Superluminal Medicines: Financing Led by Bvf Partners; Alongside Existing Investors Nvidia, Eli Lilly & Co, Cooley, and Gaingels, Among Others

THOMSON REUTERS
·
Sep 03

Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating

MT Newswires Live
·
Sep 03

Viking Therapeutics to Present at Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Sep 03

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
Sep 03

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live
·
Sep 02

Novo Nordisk A/S Stock (NVO) Moved Up by 3.17% on Sep 2: What Signal Does It Send?

TradingKey
·
Sep 02

Pharma Giant Novo Nordisk’s Stock (NVO) Jumps Even as Deutsche Bank Repeats Sell Call

TIPRANKS
·
Sep 02

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Sep 02

Scholar Rock Begins Phase 2 FORGE Trial of Apitegromab in Facioscapulohumeral Muscular Dystrophy

Reuters
·
Sep 02

Scholar Rock Says FDA Grants Fast Track Status for Apitegromab in FSHD

Reuters
·
Sep 02

Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (Fshd) Program as Participant Dosing Commences in Phase 2 Forge Trial

THOMSON REUTERS
·
Sep 02

Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Oxford BioMedica (OtherOXBDF)

TIPRANKS
·
Sep 02

World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges

TradingKey
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 01